Back to Search Start Over

Encephalomyocarditis virus 2C protein antagonizes interferon-β signaling pathway through interaction with MDA5.

Authors :
Li, Liang
Fan, Hui
Song, Zhongbao
Liu, Xuewei
Bai, Juan
Jiang, Ping
Source :
Antiviral Research. Jan2019, Vol. 161, p70-84. 15p.
Publication Year :
2019

Abstract

Abstract Encephalomyocarditis virus (EMCV) is one of the most important picornavirus. It infects many mammalian species and causes encephalitis, myocarditis, neurologic diseases, diabetes and reproductive disorders in pigs. And it evolves mechanisms for escaping innate immune responses. But the viral pathogenesis has not been understood completely. In this study, we firstly found that EMCV protein 2C is a strong IFN-β antagonist that interacts with MDA5 to inhibit induction of the IFN-β signal pathway. The mutations in amino acid residue V26 of 2C decrease the inhibition of IFN-β promoter activity and lost the ability to interact with MDA5, compared with wild type 2C protein. The rescued viruses with mutations in 2C (rV26A and rK25-3A) induced significantly higher IFN-β mRNA and protein levels in PK-15, HEK-293A and N2a cells, compared to wild type EMCV and the repaired viruses rV26A(R) and rK25-3A(R). These data indicate that the amino acid residue V26 of EMCV 2C plays important roles in inhibiting type I IFN production by interacting with MDA5. Highlights • EMCV 2C protein was screened as a novel type I IFN antagonist. • MDA5 in IFN-β signal pathway was screened to interact with EMCV 2C protein. • The amino acid V26 of EMCV 2C protein plays a crucial role in inhibiting type I IFN expression. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
01663542
Volume :
161
Database :
Academic Search Index
Journal :
Antiviral Research
Publication Type :
Academic Journal
Accession number :
133918919
Full Text :
https://doi.org/10.1016/j.antiviral.2018.10.010